From: Expression and clinical significance of long non-coding RNA HNF1A-AS1 in human gastric cancer
Characteristics | No. of case (%) | Mean ± SD | p value |
---|---|---|---|
VEGF | 0.809 | ||
0 | 15 (10.0) | 15.27 ± 3.69 | |
1 | 22 (14.7) | 15.57 ± 2.92 | |
2 | 33 (22.0) | 15.83 ± 2.72 | |
3 | 59 (39.3) | 15.94 ± 2.54 | |
4 | 21 (14.0) | 16.39 ± 3.32 | |
C-erbB-2 | 0.312 | ||
0 | 129 (86.0) | 15.70 ± 2.84 | |
1 | 5 (3.3) | 16.37 ± 2.96 | |
2 | 4 (2.7) | 15.77 ± 1.01 | |
3 | 12 (8.0) | 17.30 ± 3.21 | |
TS | 0.543 | ||
0 | 22 (14.7) | 16.41 ± 2.45 | |
1 | 53 (35.3) | 15.99 ± 2.97 | |
2 | 52 (34.7) | 15.33 ± 2.73 | |
3 | 21 (14.0) | 16.25 ± 3.34 | |
4 | 2 (1.3) | 15.92 ± 1.82 | |
BRCA1 | 0.893 | ||
0 | 10 (6.7) | 16.59 ± 1.83 | |
1 | 31 (20.7) | 16.07 ± 2.91 | |
2 | 73 (48.6) | 15.78 ± 2.57 | |
3 | 34 (22.7) | 15.61 ± 3.57 | |
4 | 2 (1.3) | 15.77 ± 5.01 | |
ERCC1 | 0.585 | ||
0 | 19 (12.7) | 15.81 ± 2.39 | |
1 | 22 (14.7) | 16.51 ± 3.61 | |
2 | 44 (29.3) | 15.96 ± 2.85 | |
3 | 41 (27.3) | 15.85 ± 3.05 | |
4 | 24 (16.0) | 15.11 ± 2.02 | |
RRM1 | 0.006 | ||
0 | 81 (54.0) | 15.79 ± 2.41 | |
1 | 10 (6.7) | 13.27 ± 4.11 | |
2 | 17 (11.3) | 15.51 ± 3.08 | |
3 | 35 (23.3) | 16.98 ± 2.93 | |
4 | 7 (4.7) | 15.48 ± 2.67 | |
Ki67 | 0.328 | ||
1 | 14 (9.3) | 16.54 ± 1.67 | |
2 | 35 (23.3) | 16.44 ± 2.79 | |
3 | 57 (38.0) | 15.48 ± 2.97 | |
4 | 44 (29.4) | 15.66 ± 3.02 | |
Syn | 0.463 | ||
0 | 128 (85.3) | 15.99 ± 2.95 | |
1 | 16 (10.7) | 15.15 ± 2.17 | |
2 | 3 (2.0) | 13.98 ± 0.87 | |
3 | 3 (2.0) | 15.59 ± 3.06 | |
CD56 | 0.364 | ||
0 | 137 (91.4) | 15.94 ± 2.86 | |
1 | 9 (6.0) | 15.66 ± 3.09 | |
2 | 2 (1.3) | 12.72 ± 0.84 | |
3 | 2 (1.3) | 14.22 ± 0.97 | |
CgA | 0.980 | ||
0 | 141 (94.0) | 15.87 ± 2.91 | |
1 | 7 (4.7) | 15.69 ± 1.83 | |
2 | 2 (1.3) | 15.63 ± 3.26 |